Data / Form D filings / Vesalius Longevity Labs (SPV) Inc.
Vesalius Longevity Labs (SPV) Inc.: Form D filings
Vesalius Longevity Labs (SPV) Inc., a biotechnology company in Vancouver, British Columbia, Canada, filed 4 Form D notices with the SEC between 2025 and 2026. The latest, on March 19, 2026, reports $6.7 million sold of a $6.7 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1500 - 1055 WEST GEORGIA STREET, Vancouver, British Columbia, Canada, V6E 4
- Phone
- (507) 666-6151
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2056924
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | New notice | $6,712,500 | $6,712,500 | 19 | Mar 11, 2026 | sec.gov | |
| May 13, 2025 | New notice | $250,000 | $250,000 | 1 | Apr 29, 2025 | sec.gov | |
| Mar 27, 2025 | New notice | $895,000 | $895,000 | 6 | Mar 14, 2025 | sec.gov | |
| Feb 19, 2025 | New notice | $1,700,000 | $1,700,000 | 6 | Feb 6, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Shannon Anderson | Director, Promoter | |
| Christina Phalen | Executive Officer, Director |
Every Form D from the week of Mar 16, 2026 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vesalius Longevity Labs (SPV) Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.